Viking Global Investors
NTLA icon

Viking Global Investors’s Intellia Therapeutics NTLA Stock Holding History

Viking Global Investors’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,569,545
Closed -$58.5M – 93
2023
Q1 		$58.5M Sell
1,569,545
-451,865
-22% -$17.7M 0.27% 60
2022
Q4 		$70.5M Buy
2,021,410
+132,343
+7% +$6.29M 0.35% 56
2022
Q3 		$106M Sell
1,889,067
-339,316
-15% -$21M 0.49% 53
2022
Q2 		$115M Sell
2,228,383
-240,377
-10% -$12.2M 0.53% 50
2022
Q1 		$179M Buy
2,468,760
+889,224
+56% +$75.3M 0.73% 38
2021
Q4 		$187M Buy
1,579,536
+300,005
+23% +$37.6M 0.54% 52
2021
Q3 		$172M Buy
1,279,531
+304,439
+31% +$46.1M 0.47% 60
2021
Q2 		$158M Buy
+975,092
New +$75.9M 0.48% 49

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return